HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ketty Peris Selected Research

Actinic Keratosis

5/2022A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.
5/2022Correction to: A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.
4/2022Treatment adherence with diclofenac 3% gel among patients with multiple actinic keratoses: an integrated low-intensity intervention program versus standard-of-care.
11/2020Photodynamic therapy with 5-aminolevulinate patch for the treatment of superficial basal cell carcinomas.
10/20205-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an Italian study in the real-life setting.
1/2020Treatment monitoring of 5-fluorouracil 0.5%/salicylic acid 10% lesion-directed therapy for actinic keratosis using dermoscopy and in-vivo reflectance confocal microscopy.
6/2018Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series.
5/2017Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT.
2/2017Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
11/2016Adherence to topical therapies in actinic keratosis: A literature review.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ketty Peris Research Topics

Disease

43Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 01/2006
27Melanoma (Melanoma, Malignant)
11/2022 - 04/2006
16Actinic Keratosis
05/2022 - 07/2003
15Neoplasms (Cancer)
07/2022 - 11/2003
15Basal Cell Carcinoma (Rodent Ulcer)
03/2022 - 02/2005
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 08/2006
11Atopic Dermatitis (Atopic Eczema)
05/2022 - 01/2002
10Skin Neoplasms (Skin Cancer)
03/2022 - 06/2003
7Hidradenitis Suppurativa
06/2022 - 01/2020
7COVID-19
03/2022 - 11/2020
7Psoriatic Arthritis
02/2021 - 08/2017
4Skin Diseases (Skin Disease)
01/2022 - 08/2016
4Neoplasm Metastasis (Metastasis)
01/2022 - 01/2010
3Inflammation (Inflammations)
01/2022 - 08/2020
3Bullous Pemphigoid (Pemphigoid)
03/2021 - 11/2013
3Hutchinson's Melanotic Freckle (Lentigo Maligna)
02/2021 - 01/2004
2Carcinogenesis
05/2022 - 01/2017
2Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 01/2019
2Infections
01/2022 - 09/2016
2HIV Infections (HIV Infection)
01/2022 - 09/2016
2Skin Manifestations
01/2022 - 01/2021
2Disease Progression
09/2021 - 09/2015
2Eczema
07/2021 - 11/2020
2Pruritus (Itching)
03/2021 - 12/2020
2Urticaria (Hives)
03/2021 - 01/2021
2Prurigo
03/2021 - 07/2020
2Pain (Aches)
12/2020 - 01/2019
2Actinic cheilitis
10/2020 - 09/2020
2Sarcoma (Soft Tissue Sarcoma)
10/2019 - 10/2008
2Lymphoma (Lymphomas)
10/2018 - 11/2008
2Stevens-Johnson Syndrome (Lyell's Syndrome)
07/2015 - 01/2009
2Hyperpigmentation
01/2015 - 01/2004
2Bowen's Disease (Disease, Bowen)
02/2008 - 08/2006
1Alopecia Areata
07/2022
1Brain Neoplasms (Brain Tumor)
07/2022
1Abscess
06/2022

Drug/Important Bio-Agent (IBA)

13Biological ProductsIBA
01/2022 - 01/2015
10Imiquimod (Aldara)FDA LinkGeneric
02/2021 - 07/2003
9Adalimumab (Humira)FDA Link
06/2022 - 10/2017
7CytokinesIBA
01/2022 - 05/2016
6Pharmaceutical PreparationsIBA
03/2022 - 01/2006
6secukinumabIBA
10/2021 - 01/2018
5dupilumabIBA
01/2022 - 01/2019
5Monoclonal AntibodiesIBA
01/2022 - 01/2021
5HhAntag691IBA
01/2021 - 01/2015
51-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2020 - 09/2007
4Adrenal Cortex Hormones (Corticosteroids)IBA
08/2022 - 01/2019
4InterleukinsIBA
01/2022 - 01/2017
4Etanercept (Enbrel)FDA Link
09/2016 - 07/2008
4tazarotene (Tazorac)FDA Link
01/2006 - 01/2004
3cemiplimabIBA
05/2022 - 01/2021
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
3Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2021 - 08/2016
3apremilastIBA
05/2021 - 08/2017
3Interleukin-23 (Interleukin 23)IBA
02/2021 - 01/2017
3betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
01/2021 - 01/2007
3calcipotriene (calcipotriol)FDA LinkGeneric
01/2021 - 01/2007
3Type 1 Melanocortin ReceptorIBA
10/2008 - 06/2003
2guselkumabIBA
06/2022 - 02/2021
2Janus Kinase InhibitorsIBA
05/2022 - 08/2020
2risankizumabIBA
02/2022 - 01/2022
2Interleukin-1 (Interleukin 1)IBA
01/2022 - 01/2021
2Interleukin-13IBA
01/2022 - 01/2021
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 01/2020
2Interleukin-17 (Interleukin 17)IBA
10/2021 - 08/2020
2ixekizumabIBA
09/2021 - 01/2021
2Ustekinumab (CNTO 1275)FDA Link
09/2021 - 11/2011
2AcitretinFDA Link
05/2021 - 01/2021
2ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2019
2sonidegibIBA
01/2021 - 10/2016
2CyclinsIBA
01/2021 - 05/2006
2baricitinibIBA
12/2020 - 10/2020
2AcidsIBA
10/2020 - 01/2004
2Janus KinasesIBA
10/2020 - 08/2020
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020 - 11/2015
2MicroRNAs (MicroRNA)IBA
10/2019 - 01/2019
2Telomerase (Telomerase Reverse Transcriptase)IBA
10/2019 - 03/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 11/2003
2InterferonsIBA
01/2016 - 10/2012
2Cetuximab (Erbitux)FDA Link
09/2015 - 09/2005
2efalizumab (Raptiva)FDA Link
12/2009 - 05/2008
1Dihydrotachysterol (AT 10)IBA
11/2022
1upadacitinibIBA
07/2022
1Diclofenac (SR 38)FDA LinkGeneric
04/2022
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
03/2022
1tildrakizumabIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1LigandsIBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022

Therapy/Procedure

34Therapeutics
08/2022 - 09/2002
8Radiotherapy
07/2022 - 02/2016
7Immunotherapy
07/2022 - 01/2020
6Photochemotherapy (Photodynamic Therapy)
11/2020 - 09/2007
5Biological Therapy
03/2022 - 01/2009
4Phototherapy (Light Therapy)
08/2022 - 10/2016
4Aftercare (After-Treatment)
10/2016 - 01/2004
3Brachytherapy
03/2022 - 08/2019
2Organ Transplantation
01/2022 - 10/2020
2Operative Surgical Procedures
02/2016 - 01/2015
1Kidney Transplantation
01/2022